Innovators in Controlled-Release Drug Delivery

At ZHI Patented Technologies, we are a team of industry veterans dedicated to transforming how bioactives like CBD reach your body—safely, effectively, and discreetly.

Founded on a passion for precision medicine, ZHI bridges the gap between cutting-edge science and everyday wellness. Our proprietary transdermal patches offer superior absorption, drawing from the best practices.

Our Story

From Pioneers to Partners in Wellness

Our journey began with a simple goal: Improve drug delivery for better patient outcomes. Today, we're revolutionizing the industry with products that provide accurate dosing over extended periods. Milestones include developing USP-grade Lidocaine patches and licensing tech to global brands—always with a focus on quality, authentication, and compliance.

Our Story

From Pioneers to Partners in Wellness

Revolutionizing Drug Delivery through Transdermal Patches

In administering medicine, getting the dosage correct is very important. Whether it is easing long-lasting pain, keeping blood pressure in check, or making sure vitamins are absorbed properly, giving the proper dosage can be beneficial in helping patients feel better.

Sometimes, conventional ways of giving medicine are not as good at controlling it as we need. That is where ZHI Technologies steps in, offering a revolutionary solution that is changing the game.

The Problem: Accurate Dosing

Conventional drug delivery methods, such as oral tablets or inhaled formulations, face inherent challenges when it comes to ensuring accurate dosing. The body’s complex physiology, including factors like fat storage and absorption kinetics, can significantly impact how drugs are absorbed and released. Once a substance enters the body through these methods, controlling or stopping the dose becomes nearly impossible, raising concerns about overdosing or underdosing.

The ZHI Patented Technologies Solution

ZHI Patented Technologies leads the way in drug delivery innovation. At the core of our breakthroughs is a simple yet revolutionary idea: controlled-release transdermal patches. Unlike traditional methods, our patches offer unmatched precision and control.

What makes ZHI’s patches special is our patented controlled-release technology, manufactured in cGMP-certified facilities. This system ensures a steady and reliable delivery of active ingredients over time. Whether cannabinoids, pain relievers, or supplements, ZHI’s transdermal patches deliver these compounds directly through the skin, bypassing traditional delivery challenges.

Meet the Experts Driving Innovation

Our seasoned team brings expertise in pharmacology, chemistry, and regulatory affairs.

Robert C. Galler

Founder, Chairman, & CEO of ZHI Technologies

Serial founder and expert in private and public finance, marketing, and business development.
Founder, Officer, and Director of Synsorb Biotech, Select Therapeutics, and Novadel Pharma (all brought to public market).
Non-Profit: Lois Joy Galler Foundation for Hemolytic Uremic Syndrome.

David Enscore, PhD

Senior Technology Advisor

PhD in Chemical Engineering with a focus on diffusion in polymers.
30+ years in controlled drug delivery, including the development of transdermal drug delivery systems such as Catapres-TTS and NicodermCQ.
Employed by numerous drug delivery companies including Alza Corporation, Focal, Inc., and Altea Therapeutics.
Consulted on delivery system development with 20+ companies.
Served as an expert technical witness in 10+ patent infringement lawsuits.
30 granted US patents, with a majority related to transdermal drug delivery.

Robert Bender

Senior Business Advisor

Over 30 years of experience in life sciences and healthcare.
Founded Sunopta, BIO LOGICALS, Neurochem, Immune Control Inc., Pharmena Inc., Atreus Pharma, Revivo Therapeutics, and Banting Corp.
Co-invented and led the team that developed the first-to-market automated DNA synthesizer at BIO LOGICALS.
Founding CEO of Neurochem, advancing a CNS asset into Ph3 before restructuring.
Co-founded Atreus Pharma to develop radiopharmaceuticals, acquired by Novartis.
Chair of Revivo Therapeutics, developing a clinical-stage asset targeting CNS indications.

Harold K. Sirota - DO, FACOFP

Medical Director

Board certified in Family Practice
Fellow of the American College of Family Practice
Chairman of the Department of Primary Care at the Touro College of Osteopathic Medicine which is in Harlem, NY. He has served in this role since its inaugural year (2007).
Earned his Doctor of Osteopathic Medicine degree from New York College of Osteopathic Medicine in Old Westbury, NY and is a member of the AOA, AMA, ACOFP, MSSNY and NYSOM societies.
Currently practicing Primary Care Concierge Medicine at Sirota Medical PLLC in Valley Stream, NY and has been delivering quality medical care to his patients for over 35 years.
Is highly regarded in the nutrition and wellness industry, working with numerous c-GMP companies providing support, guidance and leadership.
Owner of JCL Therapeutics LLC, a wellness center located in Valley Stream, NY whose focus is on weight loss, regenerative medicine, cognitive support, skin and structural integrity and immune system support.

Committed to Excellence and Ethics

USP-grade ingredients, third-party COAs, and ethical sourcing define us. We prioritize sustainability and user safety in every product.

Disclaimer

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act require this notice.